Responses
Extended report
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
Compose a Response to This Article
Other responses
No responses have been published for this article.